A detailed history of Canandaigua National Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 6,773 shares of LLY stock, worth $6.22 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
6,773
Previous 6,980 2.97%
Holding current value
$6.22 Million
Previous $4.07 Million 29.52%
% of portfolio
0.84%
Previous 0.68%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 01, 2024

SELL
$592.2 - $792.28 $122,585 - $164,001
-207 Reduced 2.97%
6,773 $5.27 Million
Q4 2023

Jan 04, 2024

SELL
$525.19 - $619.13 $95,059 - $112,062
-181 Reduced 2.53%
6,980 $4.07 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $332,545 - $458,464
765 Added 11.96%
7,161 $3.85 Million
Q2 2023

Jul 03, 2023

SELL
$350.74 - $468.98 $27,708 - $37,049
-79 Reduced 1.22%
6,396 $3 Million
Q1 2023

Apr 11, 2023

SELL
$310.63 - $364.82 $1.83 Million - $2.15 Million
-5,893 Reduced 47.65%
6,475 $2.22 Million
Q1 2020

Apr 16, 2020

SELL
$119.05 - $147.35 $75,239 - $93,125
-632 Reduced 4.86%
12,368 $1.72 Million
Q4 2019

Jan 17, 2020

SELL
$106.92 - $132.43 $139,423 - $172,688
-1,304 Reduced 9.12%
13,000 $1.71 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $212,512 - $231,158
1,990 Added 16.16%
14,304 $1.6 Million
Q2 2019

Jul 19, 2019

SELL
$110.79 - $129.32 $43,208 - $50,434
-390 Reduced 3.07%
12,314 $1.36 Million
Q1 2019

Apr 25, 2019

BUY
$111.31 - $131.02 $118,879 - $139,929
1,068 Added 9.18%
12,704 $1.65 Million
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $134,387 - $150,554
-1,269 Reduced 9.83%
11,636 $1.35 Million
Q3 2018

Nov 02, 2018

BUY
$85.86 - $107.31 $50,228 - $62,776
585 Added 4.75%
12,905 $1.39 Million
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $6,510 - $7,471
86 Added 0.7%
12,320 $1.05 Million
Q1 2018

May 09, 2018

BUY
$74.21 - $87.6 $907,885 - $1.07 Million
12,234 New
12,234 $947,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $872B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.